Holen Sie sich die Stockscreener-App
14.17
1.43%
0.20
Handel nachbörslich:
14.25
0.08
+0.56%
Finanzdaten der Intellia Therapeutics Inc-Aktie (NTLA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
1,609%
28.93
|
-1.917 | 11.99 | 13.59 | 12.61 |
Operating Expenses
|
3.60%
142.94
|
137.97 | 143.10 | 145.93 | 124.56 |
| Benefits Costs and Expenses |
4.70%
136.37
|
130.24 | 143.10 | 145.93 | 115.73 |
| Costs And Expenses |
3.60%
142.94
|
137.97 | 143.10 | 145.93 | 124.56 |
| Operating Income/Loss |
18.51%
-114.00
|
-139.89 | -131.11 | -132.33 | -111.96 |
| Income/Loss From Equity Method Investments |
100.00%
-
|
-4.728 | -3.857 | -4.00 | -3.048 |
| Income/Loss From Continuing Operations Before Tax |
18.71%
-107.44
|
-132.16 | -131.11 | -123.68 | -103.13 |
| Income/Loss From Continuing Operations After Tax |
18.71%
-107.44
|
-132.16 | -122.22 | -123.68 | -103.13 |
|
Net Income/Loss
|
18.71%
-107.44
|
-132.16 | -122.22 | -123.68 | -103.13 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
16,773%
95.50
|
0.566 | 88.64 | 88.19 | 87.77 |
| Diluted Average Shares |
16,773%
95.50
|
0.566 | 88.64 | 88.19 | 87.77 |
| Basic Earnings Per Share |
23.29%
-1.12
|
-1.46 | -1.38 | -1.40 | -1.17 |
| Diluted Earnings Per Share |
23.29%
-1.12
|
-1.46 | -1.38 | -1.40 | -1.17 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):